We are live on ! Find out more
PBC

Pavion Blue Capital Portfolio holdings

AUM $248M
1-Year Est. Return 22.79%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+22.79%
3 Year Est. Return
+77.62%
5 Year Est. Return
+100.27%
10 Year Est. Return
AUM
$215M
AUM Growth
+$11.5M
Cap. Flow
+$258K
Cap. Flow %
0.12%
Top 10 Hldgs %
43.27%
Holding
105
New
4
Increased
20
Reduced
28
Closed
3

Top Buys

Rank Stock Value
1
MKL icon
Markel Group
MKL
+$443K
2
DEO icon
Diageo
DEO
+$314K
3
WFC icon
Wells Fargo
WFC
+$279K
4
PFE icon
Pfizer
PFE
+$263K
5
NKE icon
Nike
NKE
+$225K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.03M
2
QCOM icon
Qualcomm
QCOM
+$224K
3
C icon
Citigroup
C
+$211K
4
WBD icon
Warner Bros
WBD
+$142K
5
BAC icon
Bank of America
BAC
+$92.9K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.04%
2 Financials 20.14%
3 Technology 16.18%
4 Consumer Discretionary 8.44%
5 Communication Services 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
101
Sysco
SYY
$40.3B
$219K 0.1%
2,802
VEA icon
102
Vanguard FTSE Developed Markets ETF
VEA
$236B
$211K 0.1%
+3,995
New +$203K
C icon
103
Citigroup
C
$226B
-3,331
Closed -$211K
QCOM icon
104
Qualcomm
QCOM
$176B
-1,127
Closed -$224K
WBD icon
105
Warner Bros
WBD
$67.1B
-19,082
Closed -$142K

Similar funds

Pavion Blue Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Pavion Blue Capital held 105 positions worth $215M, up 5.7% from $203M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pavion Blue Capital's Q3 2024 filing shows 4 new, 20 increased, 28 reduced and 3 closed positions. Its largest new stake was Pfizer: 8,999 shares worth $260K. The largest sale was Eli Lilly, an estimated $1.03M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

  • Pavion Blue Capital's largest Q3 2024 buy was Pfizer: 8,999 shares worth $260K.
  • Pavion Blue Capital added most to Markel Group in Q3 2024, an estimated $443K increase.
  • Pavion Blue Capital's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.03M.
  • Pavion Blue Capital fully exited Qualcomm in Q3 2024, selling an estimated $224K.
  • Pavion Blue Capital's ten largest holdings make up 43% of its $215M portfolio in Q3 2024.
  • Pavion Blue Capital opened 4 new positions and closed 3 in Q3 2024.
  • Pavion Blue Capital's portfolio value rose 5.7% quarter-over-quarter to $215M.

Based on Pavion Blue Capital's 13F filing for Q3 2024, filed 23 Oct 2024.